InvestorsHub Logo
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: ststephensrevenge post# 280012

Thursday, 12/01/2016 11:47:15 AM

Thursday, December 01, 2016 11:47:15 AM

Post# of 346903

+++PPHM will be part of the solution.

Not with this cast of characters leading the effort. Not a chance.

Partner and hand over the control...or the compound gets left in the dust and shareholders crushed.



Now my puzzle is becoming CLEARER by the day.

Thank you and many are forgetting about the fact that Big Pharma has NEVER seen Sean Parker types just step in and hand over Millions (that used to be Big Pharmas job... taking small biotechs literally by hostage..)

Out of curiosity, whom do you think would be up for such a job, that you believe could lead the PS Targeting effort? : )

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News